Systemic mastocytosis, myelofibrosis and portal hypertension.
Open Access
- 1 June 1982
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 35 (6) , 617-619
- https://doi.org/10.1136/jcp.35.6.617
Abstract
A case of systemic mastocytosis is described in which the finding on initial presentation was hepatosplenomegaly. No dermatological abnormality was present, and the bone marrow histology originally caused some confusion with primary myelofibrosis. The clinical course and the importance of distinguishing between these two diseases is discussed. The dermatological manifestation of systemic mastocytosis, in the form of urticaria pigmentosa, is well recognised, and alerts the physician to the underlying disease. In the absence of cutaneous signs, however, the diagnosis is less obvious. The case reported had predominantly marrow and splenic involvement by the disease process, giving rise to portal hypertension, and illustrates the problems of diagnosis which can arise.This publication has 10 references indexed in Scilit:
- Portal hypertension associated with systemic mastocytosis and splenomegalyGastroenterology, 1980
- Eosinophilia in Systemic MastocytosisAmerican Journal of Clinical Pathology, 1980
- Portal hypertension in systemic mastocytosisGastroenterology, 1978
- Mast Cells and MyelofibrosisAmerican Journal of Clinical Pathology, 1975
- The Spectrum of Myeloproliferative DisordersMedical Clinics of North America, 1973
- Heparin Enhancement of Factors Stimulating Bone Resorption in Tissue CultureScience, 1965
- The Mastocytosis Syndrome: Clinical and Biological StudiesAnnals of Internal Medicine, 1963
- THE FORMATION OF COLLAGEN FIBERS BY THE ACTION OF HEPARIN ON SOLUBLE COLLAGEN: AN ELECTRON MICROSCOPE STUDYThe Journal of Experimental Medicine, 1952